Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Ferm Translational Pharma Consulting AB
AB
In liquidation
Org 5569252918
Research and experimental development on biotechnology
· NACE 7211
Est. 2013
0 employees
Watchlist
Share
Sweden
/
Companies
/
Research and experimental development on biotechnology
/
Ferm Translational Pharma Consulting AB
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (1)
JL
Jonny Lennart Greinsmark
Liquidator
Liquidator
2020
Former (1)
MO
Mats Olof Torkel Ferm
Chief Executive Officer
Chief Executive Officer
2020 – 2021
Board of directors
Non-executive oversight
Name
Role
Member since
Former (1)
IM
Inger Maria Zetterström Karlsson
Deputy Board Member
2020 – 2021
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Ferm Translational Pharma Consulting AB
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network
